Page results
-
This page has information on how to treat iron overload with Desferrioxamine. It has information on how the medicine is delivered and how you can do it at home.
-
Organisations and services offering financial advice to people affected by cancer and blood conditions, and their familes and carers.
-
This page provides an overview of our Teenage and Young Adult (TYA) Ambulatory Care Service available to patients aged 12 to 24 years.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
This step-by-step guide explains how you can give yourself an injection of bortezomib at home.
-
This page provides information on transperineal biopsies of the prostate.
-
The UCLH children’s FGC/M clinic provides specialist care for children and adolescents who have undergone or are at risk of FGC/M.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
This page aims to help you decide if a post-dates induction of labour is the right decision for you and your baby.
-
This page has been written for parents and carers whose child is having a single fraction (one treatment) total body irradiation (TBI) for a benign (non-cancerous) blood disorder such as sickle cell anaemia, aplastic anaemia, thalassaemia, or some other condition.
File results
-
FOI/2022/0494 - Treatment of Haemophilia A
-
FOI/2022/0495 - International recruitment
-
FOI/2022/0497 - Departments/ specialties that have functioning air-conditioning
-
FOI/2022/0502 - Asthma treatments
-
FOI/2022/0505 - Type of needles used for insulin administration to patients
-
FOI/2022/0506 - Node positive breast cancer patients undergoing Oncotype testing
-
FOI/2022/0514 - Infant deaths/ stillbirths and cremations
-
FOI/2022/0516 - Number of orthopaedic consultants at Trust
-
FOI/2022/0517 - Mobile phone and data contracts/ spend
-
FOI/2022/0519 - Melanoma treatments